Clinartis   Report issue

For profit Phase 1
Founded: Miami FL United States (2009)

Organization Overview

First Clinical Trial
2014
NCT02253342
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Clinartis | Clinartis, LLC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Renal Insufficiency (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 9
  • # of Trial APIs: 9